PhD Pathways

2022-2023 Sessions:

Upcoming sessions:

Previous sessions:

2021-2022 Sessions

May 2022: Vidya Gopalakrishnan, PhD

Associate Professor, Dept of Pediatrics-Research, Dept of Mol and Cell Oncol, Univ of Texas MD Anderson Cancer Center

April 2022: Dominic Warrino, PhD

Senior Scientific Advisor, KCAS Bioanalytical and Biomarker Services – 2004

March 2022 – Alumni Foundations Panel
  • Andrew Lepisto, PhD, Executive Medical Science Liaison at Bristol Myers Squibb – 2005
  • Scott A Shell, PhD, Medical Science Liaison for Guardant Health – 2005
  • Michael Turner, PhD, Senior Medical Science Liaison at GSK – 2005
  • Christopher Herrem, PhD, Senior Scientific Director, Global Medical Affairs and AbbVie – 2004
  • Kamal Khanna, PhD Associate Professor at NYU Langone Health, Department of Microbiology – 2004

February 2022: Jonathan Steckbeck, PhD

Founder, President & CEO, Peptilogics - 2012 Biochemistry & Molecular Genetics

January 2022: Elaine Jones, PhD

Experienced board director, successful venture capitalist, and skilled pharmaceutical executive – 1981 Microbiology

Dec 2021: Devin Dressman, PhD

Associate Director of Researh Operations and Strategy, UPMC Hillman Cancer Center, Assistant Professor, Dept. of Pathology, University of Pittsburgh School of Medicine - 2002 Biochemistry & Molecular Genetics

Nov 2021: Andrea Hassett, PhD

Vice President , Clinical Services Administration, Vitalant Specialty Labs & Therapeutics - 1987 Pathology

Oct 2021: Richard Creager, PhD

Co-Founder & Partner, NaviDx LLC - 1981 Microbiology